• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Biotech Market
    Biotech News
    Biotech Stocks
    • Biotech Market
    • Biotech News
    • Biotech Stocks

    Biogen to Report Third Quarter 2016 Financial Results

    Chelsea Pratt
    Sep. 15, 2016 01:31AM PST
    Biotech Investing

    Biogen today announced it will report third quarter 2016 financial results on Wednesday, October 26, 2016, before the financial markets open. Following the release of the financials, the Company will host a live webcast where Biogen management will discuss the financial results, at 8:30 am ET.

    CAMBRIDGE, Mass.–(BUSINESS WIRE)–Biogen Inc. (NASDAQ:BIIB) today announced it will report third quarter 2016 financial results on Wednesday, October 26, 2016, before the financial markets open.
    Following the release of the financials, the Company will host a live webcast where Biogen management will discuss the financial results, at 8:30 am ET. To access the live webcast, please go to the investor relations section of Biogen’s website at www.biogen.com/investors.
    Following the live webcast, an archived version of the call will be available at the same URL, for one month.
    About Biogen
    Through cutting-edge science and medicine,
    Biogen discovers, develops and delivers worldwide innovative therapies
    for people living with serious neurological, autoimmune and rare
    diseases. Founded in 1978, Biogen is one of the world’s oldest
    independent biotechnology companies and patients worldwide benefit from
    its leading multiple sclerosis and innovative hemophilia therapies. For
    more information, please visit www.biogen.com.
    Follow us on Twitter.

    multiple sclerosisrare diseasesbiotechnology companiesfinancial results
    The Conversation (0)

    Go Deeper

    AI Powered
    Biotech Investing

    Q BioMed Inc. Provides Important Update on Mannin Research Tie2 Technology Platform Development

    Assembly Biosciences Announces First Quarter 2018 Financial Results

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Biotech Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×